Pediatrix Medical Group, Inc. (MD) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Pediatrix Medical Group, Inc.

Azenta, Inc.

Lifestance Health Group, Inc.

Hims & Hers Health, Inc.

RadNet, Inc.

Addus HomeCare Corp.

U.S. Physical Therapy, Inc.

NeoGenomics, Inc.

Ginkgo Bioworks Holdings, Inc.

OPKO Health, Inc.

Celldex Therapeutics, Inc.

Why is Pediatrix Medical Group, Inc. ?

With a growth in Net Profit of 89.32%, the company declared Very Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD 244.56 MM
ROCE(HY) Highest at 14.27%
INTEREST COVERAGE RATIO(Q) Highest at 755.9

With ROCE of 16.57%, it has a risky valuation with a 1.35 Enterprise value to Capital Employed

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 49.70%, its profits have risen by 44.5% ; the PEG ratio of the company is 0.2

Market Beating Performance

The stock has generated a return of 49.70% in the last 1 year, much higher than market (S&P 500) returns of 13.22%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Pediatrix Medical Group, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Pediatrix Medical Group, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Pediatrix Medical Group, Inc.

49.7%

4.37

50.99%

S&P 500

13.22%

0.65

20.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-9.23%

EBIT Growth (5y)

-7.17%

EBIT to Interest (avg)

3.79

Debt to EBITDA (avg)

2.77

Net Debt to Equity (avg)

0.51

Sales to Capital Employed (avg)

1.33

Tax Ratio

1.59%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

13.11%

ROE (avg)

14.52%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.53

EV to EBIT

8.16

EV to EBITDA

7.17

EV to Capital Employed

1.35

EV to Sales

0.82

PEG Ratio

0.19

Dividend Yield

ROCE (Latest)

16.57%

ROE (Latest)

19.10%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 244.56 MM

ROCE(HY)

Highest at 14.27%

INTEREST COVERAGE RATIO(Q)

Highest at 755.9

RAW MATERIAL COST(Y)

Fallen by -23.03% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 36.13 %

DEBTORS TURNOVER RATIO(HY)

Highest at 7.45 times

OPERATING PROFIT(Q)

Highest at USD 69.01 MM

OPERATING PROFIT MARGIN(Q)

Highest at 14.72 %

PRE-TAX PROFIT(Q)

Highest at USD 58.8 MM

EPS(Q)

Highest at USD 0.46

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Pediatrix Medical Group, Inc.

Interest Coverage Ratio

Highest at 755.9

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Cash Flow

Highest at USD 244.56 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit

Highest at USD 69.01 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin

Highest at 14.72 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at USD 58.8 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD 58.8 MM has Grown at 47.24%

over average net sales of the previous four periods of USD 39.94 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

EPS

Highest at USD 0.46

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debt-Equity Ratio

Lowest at 36.13 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 7.45 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -23.03% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales